Cargando…

The MicroRNA-106a/20b Strongly Enhances the Antitumour Immune Responses of Dendritic Cells Pulsed with Glioma Stem Cells by Targeting STAT3

BACKGROUND: Evaluate the effect of the miRNA-106a/20b on the efficacy of DCs pulsed with GSCs in activating GSC-specific T cell responses. METHODS: We cultured GSCs and prepared GSC antigen lysates by apoptosis. Then, immature DCs were pulsed with GSC antigen lysates in vitro. STAT3 levels in DCs we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Hui, Sun, Chengmei, Li, Cong, Hua, Shiting, Li, Feng, Li, Ruichun, Cai, Dongpeng, Zou, Yuxi, Cai, Yingqian, Jiang, Xiaodan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499788/ https://www.ncbi.nlm.nih.gov/pubmed/36157880 http://dx.doi.org/10.1155/2022/9721028

Ejemplares similares

PTBP1 is necessary for dendritic cells to regulate T‐cell homeostasis and antitumour immunity
por: Geng, Guangfeng, et al.
Publicado: (2021)

Intracranial dissemination in a primary small cell carcinoma of the brain: a case report and literature review
por: Sun, Yesheng, et al.
Publicado: (2023)

Dynamics of an Antitumour Model with Pulsed Radioimmunotherapy
por: Wang, Gang, et al.
Publicado: (2022)

Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity
por: Huang, Tu-Xiong, et al.
Publicado: (2022)

Mesenchymal stem cells protect against TBI-induced pyroptosis in vivo and in vitro through TSG-6
por: Feng, Zhiming, et al.
Publicado: (2022)

Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells
por: Zhao, Yinghua, et al.
Publicado: (2016)

A Novel In Situ Dendritic Cell Vaccine Triggered by Rose Bengal Enhances Adaptive Antitumour Immunity
por: Zhang, Lanlin, et al.
Publicado: (2022)

Bone Marrow-Derived Mesenchymal Stem Cells Maintain the Resting Phenotype of Microglia and Inhibit Microglial Activation
por: Yan, Ke, et al.
Publicado: (2013)

Human umbilical cord mesenchymal stem cell-derived exosomal miR-146a-5p reduces microglial-mediated neuroinflammation via suppression of the IRAK1/TRAF6 signaling pathway after ischemic stroke
por: Zhang, Zhongfei, et al.
Publicado: (2021)

Anti-CD40-induced inflammatory E-cadherin+ dendritic cells enhance T cell responses and antitumour immunity in murine Lewis lung carcinoma
por: Zhang, Yong, et al.
Publicado: (2015)

Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine
por: Sioud, Mouldy, et al.
Publicado: (2016)

Antitumour Antibiotics
por: Fox, B. W.
Publicado: (1979)

An Overview of Antitumour Activity of Polysaccharides
por: Jin, Hongzhen, et al.
Publicado: (2022)

Natural killer cells in antitumour adoptive cell immunotherapy
por: Laskowski, Tamara J., et al.
Publicado: (2022)

Recent Advances in Functional Carbon Quantum Dots for Antitumour
por: Cai, Rong, et al.
Publicado: (2021)

Diversification of dendritic cell subsets: Emerging roles for STAT proteins
por: Li, Haiyan S, et al.
Publicado: (2013)

Blockade of MIF–CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma
por: Figueiredo, Carlos R., et al.
Publicado: (2018)

The critical role that STAT3 plays in glioma-initiating cells: STAT3 addiction in glioma
por: Ganguly, Debolina, et al.
Publicado: (2018)

STAT1 is regulated by TRIM24 and promotes immunosuppression in head and neck squamous carcinoma cells, but enhances T cell antitumour immunity in the tumour microenvironment
por: Anderson, Kelvin, et al.
Publicado: (2022)

Antitumour activity of peroxidases.
por: Everse, K. E., et al.
Publicado: (1985)

The antitumour activities of statins
por: Takahashi, H.K., et al.
Publicado: (2007)

miR-141 inhibits glioma vasculogenic mimicry by controlling EphA2 expression
por: Li, Guoxiong, et al.
Publicado: (2018)

Exosomes Derived from Hypoxic Glioma Cells Reduce the Sensitivity of Glioma Cells to Temozolomide Through Carrying miR-106a-5p
por: Wu, Peizhang, et al.
Publicado: (2022)

MiR-106b exhibits an anti-angiogenic function by inhibiting STAT3 expression in endothelial cells
por: Maimaiti, Ailifeire, et al.
Publicado: (2016)

Dendritic cell vaccines for high-grade gliomas
por: Eagles, Matthew E, et al.
Publicado: (2018)

Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer
por: Ding, Zhenyu, et al.
Publicado: (2021)

Tin-based Antitumour Drugs
por: Gielen, Marcel
Publicado: (1994)

The realisation of targeted antitumour therapy
por: Bicknell, R
Publicado: (2005)

Antitumour Drug-Radiation Interactions
por: Carmichael, J.
Publicado: (1992)

Antitumour responses induced by short-term pretreatment with tumour cells.
por: James, K., et al.
Publicado: (1978)

MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma
por: Cai, Kemin, et al.
Publicado: (2011)

Zoledronate-pulsed dendritic cell-based anticancer vaccines
por: Kamigaki, Takashi, et al.
Publicado: (2013)

Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of T(H)9 cells
por: Rivera Vargas, Thaiz, et al.
Publicado: (2017)

Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM
por: Dai, Dong-Wei, et al.
Publicado: (2013)

Glioma Stem Cell-Targeted Dendritic Cells as a Tumor Vaccine Against Malignant Glioma
por: Ji, Baowei, et al.
Publicado: (2013)

Pseudoginsengenin DQ exerts antitumour activity against hypopharyngeal cancer cells by targeting the HIF-1α-GLUT1 pathway
por: Wang, Sanchun, et al.
Publicado: (2021)

Inhibition of dendritic cell maturation and activation is mediated by STAT3
por: Bauer, K, et al.
Publicado: (2009)

Simvastatin Impairs Growth Hormone-Activated Signal Transducer and Activator of Transcription (STAT) Signaling Pathway in UMR-106 Osteosarcoma Cells
por: Sandoval-Usme, María Claudia, et al.
Publicado: (2014)

CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma
por: Li, Hongwen, et al.
Publicado: (2023)

Molecular Characterization of Antigen-Peptide Pulsed Dendritic Cells: Immature Dendritic Cells Develop a Distinct Molecular Profile when Pulsed with Antigen Peptide
por: Yang, Amy X., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t18or3d82mdjalrapkdhk0u9m1